Alnylam Pharmaceuticals | ALNY - Eps Utile Per Azione


Fiscal Calendario Efettivo Consenso Precedente Data
FY2026Q3 Sep/2025 1.97 2.90 Oct/29
FY2026Q2 Jun/2026 1.84 1.61 0.32 Jul/30
FY2026Q1 Mar/2026 1.99 0.99 -0.01 Apr/30
FY2025Q4 Dec/2025 1.25 1.27 0.06 Feb/12
FY2025Q3 Sep/2025 2.90 0.27 -0.50 Oct/30




Eps Cambiamento Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Agios Pharmaceuticals USD -1.69 0 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
Arrowhead Research USD -1.36 0.43 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Moderna USD -1.97 1.43 2026-06
Neurocrine Biosciences USD 2.85 0.91 2026-06
Novartis USD 1.99 0.45 2026-03
PTC Therapeutics USD 0.92 0.95 2026-06
Regeneron Pharmaceuticals USD 14.29 4.82 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 2.17 2.84 2026-03
Sarepta Therapeutics USD 0.64 2.52 2026-06
Takeda JPY 71.65 87.21 2026-06
Tectonic Therapeutic USD -1.34 0.32 2026-03
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06
Xencor USD -0.29 1.42 2026-06